Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children

Launched by ASSIUT UNIVERSITY · Nov 2, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the causes and risk factors that lead to a condition called chronic portal vein thrombosis in children. The portal vein is an important blood vessel that carries blood from the digestive organs to the liver, and when it gets blocked, it can cause serious health issues. The study aims to find out more about this condition and to develop a plan for managing it effectively in young patients.

To be part of this trial, children and teenagers aged between 3 months and 18 years who have been diagnosed with chronic portal vein thrombosis will be eligible. The study will take place at Assiut University Children Hospital, where researchers will look at patients who were admitted for this condition last year. Participants can expect to receive specialized care and be part of a program that aims to improve treatment options for chronic portal vein thrombosis. It's important to note that this trial is not yet recruiting, so it will be some time before they start accepting participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Children and adolescents with Chronic Portal vein thrombosis admitted to Pediatric Gastroenterology, Hepatology and Endoscopy units at Assiut university children hospital (AUCH) in the previous year 2022 from 1/1/2022 to 31/12/2022.
• • Those with chronic portal vein thrombosis aged from 3 months to 18 years' old.
• Exclusion Criteria:
• • Patients aged less than 3 months and more than 18 years' old. Those with acute portal vein thrombosis. Children with portal hypertension in absence of chronic portal vein thrombosis.